1.25
price up icon4.17%   0.05
pre-market  Pre-mercato:  1.25  
loading

Lineage Cell Therapeutics Inc Borsa (LCTX) Ultime notizie

pulisher
Jun 15, 2026

Lineage Cell Therapeutics joins panel on novel treatments at Clinical Trials at the Summit - Traders Union

Jun 15, 2026
pulisher
Jun 12, 2026

Lineage Cell Shareholders Reaffirm Governance and Executive Pay - TipRanks

Jun 12, 2026
pulisher
Jun 12, 2026

Lineage Cell (NYSE: LCTX) investors back board, say-on-pay as OPC1 grant bid withdrawn - Stock Titan

Jun 12, 2026
pulisher
Jun 07, 2026

LCTX Q1 2026 Earnings: EPS Miss Reflects Ongoing R&D InvestmentTrough Earnings Signal - newsline.com

Jun 07, 2026
pulisher
Jun 06, 2026

LCTX Q1 2026 Earnings: EPS Misses Estimates by 47% as Company Continues Clinical DevelopmentReturn On Assets - newsline.com

Jun 06, 2026
pulisher
Jun 04, 2026

How The Lineage Cell Therapeutics (LCTX) Story Is Shifting With New Data And Analyst Targets - Yahoo Finance

Jun 04, 2026
pulisher
Jun 02, 2026

LCTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 02, 2026
pulisher
May 29, 2026

Lineage Cell Therapeutics (LCTX) price target increased by 14.58% to 5.61 - MSN

May 29, 2026
pulisher
May 29, 2026

LCTX Q1 2026 Earnings: Wider Loss Than Expected Amid Ongoing Pipeline DevelopmentForward EPS Estimate - newsline.com

May 29, 2026
pulisher
May 29, 2026

LCTX Q1 2026 Earnings: Missed Estimates as R&D Spending Weighs on Bottom LineHealthcare Earnings Report - The Legal Advocate

May 29, 2026
pulisher
May 28, 2026

Lineage Cell Therapeutics (LCTX) Gains 3% as Biotech Sector Finds SupportNHNL Ratio - The Legal Advocate

May 28, 2026
pulisher
May 28, 2026

Lineage Cell Therapeutics Inc. (LCTX) Q1 2026 Earnings: EPS Misses Estimates Amid Pipeline Progress, Stock Rises 3.08%Annual Earnings Summary - The Legal Advocate

May 28, 2026
pulisher
May 28, 2026

Lineage Cell Therapeutics spotlights CEO participation in fireside chat with HCWCO at BioConnect - Traders Union

May 28, 2026
pulisher
May 28, 2026

Lineage Cell Therapeutics Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Biotech Continues Pipeline InvestmentEstimate Accuracy - newsline.com

May 28, 2026
pulisher
May 26, 2026

Promising Penny Stocks To Consider In May 2026 - simplywall.st

May 26, 2026
pulisher
May 26, 2026

Lineage Cell Therapeutics Inc. (LCTX) Q1 2026 Earnings: Miss on EPS as Clinical-Stage Biotech Continues DevelopmentROA Comparison - newsline.com

May 26, 2026
pulisher
May 25, 2026

Lineage Cell Therapeutics (LCTX) Slides 1.52% – Testing Key Support Near $1.23Fear Greed Extreme - newsline.com

May 25, 2026
pulisher
May 24, 2026

LCTX Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Biotech Reports No Revenue - The Legal Advocate

May 24, 2026
pulisher
May 22, 2026

Lineage reports positive 36-month findings on GA cell therapy - Eyes On Eyecare

May 22, 2026
pulisher
May 21, 2026

Earnings Preview: LCTX to Report Financial Results Post-market on May 12 - Moomoo

May 21, 2026
pulisher
May 20, 2026

Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets - Investing News Network

May 20, 2026
pulisher
May 18, 2026

Lineage Cell Therapeutics, Inc. Common Stock (NY: LCTX - FinancialContent

May 18, 2026
pulisher
May 18, 2026

Lineage Cell Therapeutics, Inc. Common Stock (NYSE:LCTX) Stock Quote - FinancialContent

May 18, 2026
pulisher
May 15, 2026

Lineage Cell Therapeutics Q1 Earnings Call Highlights - sharewise.com

May 15, 2026
pulisher
May 14, 2026

Lineage Cell Therapeutics Q1 2026 earnings preview - MSN

May 14, 2026
pulisher
May 14, 2026

Lineage Cell Therapeutics featured in European Pharmaceutical Review report on scalable cell therapies - Traders Union

May 14, 2026
pulisher
May 14, 2026

Lineage Cell Therapeutics (LCTX) Returns To Loss In Q1 2026 Challenging Profitability Narratives - Sahm

May 14, 2026
pulisher
May 13, 2026

Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses - TipRanks

May 13, 2026
pulisher
May 13, 2026

Q1 2026 Lineage Cell Therapeutics Inc Earnings Call Transcript - GuruFocus

May 13, 2026
pulisher
May 13, 2026

Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 13, 2026
pulisher
May 13, 2026

Lineage targets operations into Q2 2028 as it launches COR1 and scales ILT1 manufacturing - MSN

May 13, 2026
pulisher
May 13, 2026

Lineage Cell (LCTX) reports Q1 loss, lags revenue estimates - MSN

May 13, 2026
pulisher
May 13, 2026

Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - BioSpace

May 13, 2026
pulisher
May 13, 2026

Lineage Cell Therapeutics (LCTX) Reports Q1 2026 Earnings and St - GuruFocus

May 13, 2026
pulisher
May 13, 2026

TradingKey - TradingKey

May 13, 2026
pulisher
May 13, 2026

Lineage Cell Therapeutics Inc (LCTX) Q1 2026 Earnings Call Highl - GuruFocus

May 13, 2026
pulisher
May 12, 2026

Lineage Cell Therapeutics (LCTX) Reports Q1 Results and Advancem - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Is Lineage Cell Therapeutics (LCTX) Overvalued After Q1 2026 EPS - GuruFocus

May 12, 2026
pulisher
May 12, 2026

Lineage Cell (LCTX) Receives Funding to Support Operations Throu - GuruFocus

May 12, 2026
pulisher
May 12, 2026

LCTX: Pipeline expansion, manufacturing progress, and strong cash runway drive 2026 outlook - TradingView

May 12, 2026
pulisher
May 12, 2026

LCTX: Strong pipeline expansion and robust cash position support continued clinical and manufacturing progress - TradingView

May 12, 2026
$31.20
price up icon 2.60%
$92.22
price up icon 3.04%
$53.70
price down icon 0.94%
$61.80
price up icon 11.55%
ONC ONC
$262.68
price down icon 0.47%
$157.77
price up icon 0.76%
Capitalizzazione:     |  Volume (24 ore):